# VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

> **NCT01579591** · PHASE3 · UNKNOWN · sponsor: **Catholic University of the Sacred Heart** · enrollment: 160 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **OTHER:** VSL#3
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01579591
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2012-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579591, "VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01579591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*